The REgistry Study on Multimodality trEAtment foR Cerebral Hemorrhage

The REgistry Study on multimodality trEAtment foR Cerebral Hemorrhage (RESEARCH) aims to address these challenges by establishing a comprehensive national registry. This initiative will collect detailed, longitudinal data on the clinical characteristics, treatment modalities, and outcomes of patients with ICH across various regions. By leveraging a wide array of treatment data - including medical management, surgical interventions, and rehabilitative strategies - the RESEARCH registry intends to provide a granular view of current treatment landscapes and their direct impact on patient recovery and quality of life.

NCT Number	NCT06629532
Lead Sponsor	Tao Liu Collaborators: Tianjin Medical University General Hospital, Xuanwu Hospital, Beijing
Conditions	Intracerebral Hemorrhage
Enrollment	100,000 participants
Start Date	2024-10-15
Primary Completion	2044-10-15 (estimated)
Study Completion	2049-10-15 (estimated)
Updated on ClinicalTrials.gov	2024-10-08